Medicinal Chemistry of Leading Drugs

This course will provide an introduction to the drug discovery process using case histories in various therapeutic areas. Following an analysis of the leading prescription drugs and their physicochemical properties which ensure they are ‘drug-like’, case histories will focus on target identification and validation, design and synthesis of relevant molecules, structure activity relationships and a summary of the pharmacokinetic properties of the selected drugs. Therapeutic areas which will be discussed include antihypertensives, anxiolytics and antidepressants, anti-viral agents and antihyperlipidaemia agents and will cover both earlier drugs in the field as well as the most recent advances.

The goal of the class is to provide an introduction to the challenging discipline of medicinal chemistry so that each student can appreciate the role of chemistry in drug discovery. While background training in organic chemistry is helpful, the topics discussed are widely applicable to small molecule drug discovery and are more readily illustrated in the case studies that form the bulk of the course material.

Course Number: BIOL-40161
Credit: 1.00 unit(s)
Related Certificate Programs: Drug Discovery and Development

+ Expand All

5/2/2023 - 6/6/2023

$425

Live Online

Closed

• SECTION ID:

  171105

• CLASS TYPE:

  Synchronous web-based class meetings that are scheduled to meet online at published times (time/date).

• INSTRUCTOR:
  

  Wade, Warren, Director of Medicinal Chemistry, BioBlocks, Inc.

  Warren Wade is a drug discovery research project leader with a background in medicinal chemistry. He has proven experience discovering new compounds and progressing them into clinical trials. His strengths include creative solutions to difficult problems, leading multidisciplinary teams and long term results-oriented planning and execution. He is committed to developing real drugs for real diseases in real people. Wade is the director of medicinal chemistry at BioBlocks, Inc. where he is involved in the discovery of multiple drug candidates. Previously, he spent 7 years at Neurocrine Biosciences as a director of medicinal chemistry where he advanced two small molecule candidates for IND filing. He is an author of over 40 publications and a co-inventor on 6 issued U.S. patents. ...Read More

• TEXTBOOKS:

  No textbook required.

• POLICIES:

  No refunds after: 5/9/2023.
  

• NOTE:

DATE	DAY	START	END	LOCATION
5/2/2023	Tue	6:00 p.m.	8:00 p.m.
5/9/2023	Tue	6:00 p.m.	8:00 p.m.
5/16/2023	Tue	6:00 p.m.	8:00 p.m.
5/23/2023	Tue	6:00 p.m.	8:00 p.m.
5/30/2023	Tue	6:00 p.m.	8:00 p.m.
6/6/2023	Tue	6:00 p.m.	8:00 p.m.